This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
One major challenge of cancer treatment is metastatic disease development. The 5-year survival rate of cancer patients who
have developed distant metastasis at diagnosis is extremely low, highlighting the importance of prediction and early detection
of metastasis in cancer patients, which would definitely improve their prognosis as suitable patient therapeutic management
and treatment strategy can be provided. Cancer cells from a primary site give rise to a metastatic tumor via a number of steps,
requiring the involvement and alteration of a series of regulators. Hence, these regulators may serve as biomarkers for predicting
metastasis. In this talk we will discuss some recent findings from our laboaratoy and other research groups on how these regulators
are correlated with prediction of future metastasis.
Lui NG obstained his B.Sc. and M.Phil. from the Chinese University of Hong Kong and completed his Ph.D. from the University of Hong Kong Faculty
of Medicine in 2012. He is currently a postdoctoral fellow at the same department, working on identification of novel regulators in cancer signaling
pathways, screening of biomarkers for detecting cancer formation and progression and testing the efficacy of new drugs in combating cancers
including hepatocellular carcinoma, colorectal cancer and leukemia.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals